Brinda Balakrishnan

This profile gathers the share dealings of Brinda Balakrishnan in Aurinia Pharmaceuticals Inc. We count 3 filings; the first trade dates from 18 May 2023 and the latest from 21 May 2024.

On the market, this insider has only sold: 1 sale, €2,750 in total. Outside the open market, there are 1 share grant and 1 option exercise. In 2024 alone, the filings show no purchases and 1 sale.

Most recently, on 22 May 2024, the filings show an open-market sale worth €2,750 in Aurinia Pharmaceuticals Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.